Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
ESMO Congress 2025
ACS Clinical Congress 2025
2025 ASCO Quality Care Symposium
2025 ASTRO Annual Meeting
2025 Debates and Didactics in Hematology and Oncology
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
ESMO Congress 2025,ESMO Congress 2025
«
1
»
Advertisement
Advertisement
Oct
17
Today In Oncology
Thymic Health Associated With ICI Response
First-Line PD-1/PD-L1 Inhibitors vs BRAF Plus MEK Inhibitors in BRAF V600E-Mutated Metastatic NSCLC
Multidisciplinary Program Doubles Lung Cancer Screening Rates
New Leadership Elected to the American Society of Hematology
Lisaftoclax Regimens Effective in Plasma Cell Disorders
View More
Advertisement
